Monitoring Patient Glucose Levels: New Advances in software make it easier
...s and to view trends. A physician can read trends over a day or a week, and this product gives fast access to information that can be used to identify events that cause hypoglycemic or hyperglycemia, to track responses to activity, medication and diet and to provide more data for clinical decision-making...New Advances in Gastric Diagnostics: Smaller is Better
...construction scanning, allowing ultrasound imaging over a wider range that wa impossible with previous systems....Digital vs. Analog Mammography
...by a series of smaller (100m) photo diodes arrayed over a flat panel measuring 19 x 23 cm. The special res...t certain efficacies of full-field digital imaging over film-based screening. For instance, one study published in the journal Medical Physician, found that...Point of Care Strep Tests Speed Treatment, Lower Costs
...ion rate between patients tested with a rapid test over a throat culture. Thirty-five CLIA-waived antigen tests that test directly from throat swabs are currently available from 26 different biomedical firms, making this assay the most broadly produced point of care diagnostic kit. Among the most popula...Fast, Accurate Influenza A/B Antigen Detection
...ferentiated diagnosis of Influenza A and B in just over 15 minutes. Assay advantages include superior performance with mucoid samples, specimen flexibility and performance equivalent to 14-day viral culture, thus decreasing overall diagnostic costs by making additional ancillary testing unnecessary. Whil...PSA TestingHow Much is Too Much?
... procedure in grave doubt. Indeed, The PSA era is over in the United States, said Thomas Stamey, MD, professor of urology and lead author of the study published in the October 2004 issue of the Journal of Urology. Our study raises a very serious question of whether a man should even use the PSA test for ...Bench-Top Centrifuges--Basic Tools for the Small Lab
... trouble-free service for many thousands of cycles over many years of steady use. For those considering a replacement or initial purchase, however, here is a brief overview of several of the most popular bench-top models suitable for the small laboratory. All are manufactured by medical device firms with ...Rapid Flu Tests May Prove Especially Helpful This Season
...erentiated diagnosis of Influenza A and B. in just over 15 minutes. Assay advantages include superior performance with mucoid samples, specimen flexibility,and performance equivalent to 14-day viral culture, thus decreasing overall diagnostic costs by making additional ancillary testing unnecessary. Fina...Lab Automation Networks Proliferating
...e driven, consists of several testing stages along over 100 feet of dual conveyor track. The systems robot...ng the system components on-line in several stages over a period of months or years. [Note: The companys website includes a lengthy and highly informative w...Analyzers Offer Point-of-Care Lipid Panels
...sting. Three AAA batteries supply enough power for over 1000 tests. Test strips have a long shelf life and require no refrigeration. In addition to the three devices described above, several cholesterol analyzers have been cleared for home use, and there is a range of test strips that do not require anal...Tight Glycemic Control in the ICU
...ve care units (ICUs) has not improved dramatically over the past decades, despite the development of high-...es have shown that the Accu-Chek meter is accurate over a wide range of glucose concentrations. QC tests include a linearity kit, and glucose control solut...Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
... (named 1A2, 2C9, 2C19, 2D6, 2E1, 3A4) account for over 90% of drug metabolism (but do not appear to account for the selectivity of BiDil). Since a patient can take several concurrent medications metabolized by the same CYP enzyme, it should come as no surprise that CYP-related drug interactions are comm...Appendicitis: Evolving Tools to Diagnose a Classic Disease
...lications, already elevated for children and those over 50, rises as appendectomy is delayed. To compound...of patients with appendicitis, however, have a WBC over 10K. A study with excellent sensitivity is serum C-reactive protein (CRP), a marker of systemic inf...Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
... Harvard Medical School Contributing Editor With over 200,000 new cases and 40,000 deaths per year, brea...-2/neu. An excess of Her-2/neu probe fluorescence over control probe fluorescence indicates Her-2/neu amplification. Challenges of FISH include higher cos...New Point-of-Care Methods to Measure Coronary and Cerebrovascular Risk
...urden of the United States, with an annual cost of over $100 billion. This includes over 1.5 million myocardial infarctions annually. Atherosclerosis technically occurs in everyone 25 and ...Avian (Bird) Flu: Is There a Role for Rapid Tests?
...e fatality rate for human H5N1 infections has been over 50%. Furthermore, the H5N1 subtype shows resistance to two mainstays of influenza therapy, amantadine and rimantadine. While medications of choice currently include oseltamivir and zanamivir, there have also been reports of oseltamivir resistance (...Managing Preanalytical Processes for Patient Safety
...erry Jo Gile, MT(ASCP)MA Ed. "The Safety Lady" has over 40 years experience as a certified medical technologist. As President of her own consulting firm, Safety Lady, LLC, she is a world renowned speaker and consultant who helps organizations create safety savvy laboratories. See below, and visit our co...Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
...way to determine a patient's blood glucose control over the past 2-3 months. Specifically, the test measures the concentration of glycosylated hemoglobin. A1C levels are measured upon diagnosis, and, depending on a patient's type of diabetes, how well it is controlled, and his or her health-care provider,...Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
...ariety of report forms, or communicate with a host over a serial link. Quality control data management is offered in even the simplest cell counters, with programs ranging from basic QC data retrieval and analysis to internet-based real-time data sharing systems. Beyond improving user safety and convenien...Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
...nts, methods, and then monitoring their competency over time is a formidable task which increases with each test introduced and with department size. It is easier to decentralize the test itself than it is to decentralize the specialized laboratory knowledge and training that goes with each test. Lack of...Rapid HIV Testing Increases Possibility of Treatment
...stimated high of 40.3 million people in 2005, with over 3 million deaths caused by AIDS. The latest data from the Centers for Disease Control shows that over one million people in the United States are now living with HIV/AIDS and with 24 27% undiagnosed an...Non-Invasive Diagnostic Tests for Celiac Disease
...sue transglutaminase (tTG) IgA autoantibodies have over 95 percent sensitivity, and close to 100 percent specificity, whereas biopsy with a strict cut-off requiring villous atrophy has high specificity, but poor sensitivity. The question of who should be screened for CD remains controversial. Although it...Antibiotics Don't Prevent Future Urinary Tract Infections, May Cause Resistance in Future Infections
... for developingrecurrent kidney infections, which, over time, can cause damage tothe kidneys. However, Dr. Conway summarized, "The majority ofchildren have lower grade VUR and this lower grade VUR was notassociated with an increased risk of recurrent UTI in ourstudy." Grants from the National Institutes ......) (p=0.0166). Both the TOTPAR4 (total pain relief over 4 hours, summed painrelief scores) and SPID4 (summ...ed pain intensity difference scorespatients report over first 4 hours after initiation of dosing)values for the first dose of AeroLEF(TM) showed statistical......for adalimumab plasma concentration, the AUC over the 14 days following administration was higher when the HUMIRA was co-injected with rHuPH20 compared to the HUMIRA injection without rHuPH20 for 100% (15/15) of the patients in the study. -- The modeled population PK analysis es...Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
...need, and we look forward to seeingadditional data over the next year, leading to the opportunity tobring ...sthroughout the world. The company currently sells over 52diagnostic products through a global distribution. More informationis available at www.corgenix.co......uce treatment costs of advanced CADpatients by 20% over a five-year period after treatment. Here is a lin...lly reduce total treatment costs, by as muchas 20% over five years. We are looking forward to gatheringevidence from the ongoing clinical trials to conclusi...Molecular Target of Bradmer's Neuradiab Further Validated by Independent Findings
...uringthe course of development at Duke University, over US$60 million inresearch grants and related suppor... of brain cancer,glioblastoma multiforme. To date, over US$60 million in grants andrelated support has driven research and development of the licensedtreatm......gene activity levels by67.6 percent to 287 percent over the CMV-driven therapy in threelines of pancreatic cancer. Lab experiments showed gene activitywas limited to pancreatic cancer cells and was minimal or absentfrom other cancers and three lines of normal pancreatic, lung andbreast cells. The next st...ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
...f birth forpossible future medical use in treating over 40 diseases includingcertain blood cancers and genetic diseases. ViaCell also conductsresearch and development primarily to investigate other potentialtherapeutic uses of umbilical cord blood-derived stem cells and ontechnology for expanding populati......cularly when accompanied by prolongedbed rest, age over 60, or a previous history of VTE. About COR (Center for Outcomes Research) The Center for Outcomes Research (COR) serves as the scientificcoordinating center for a growing number of national andinternational outcomes registries. COR's responsibilit...Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
...herapy andbiological drugs for a superiority claim over the current standardof care. In that context, the FDA provided comments on the designof our Phase III colorectal cancer trial," said Dr. Platt. DAVANAT(R) as a Functional Excipient The Company is using Section 505 (b)(2) to obtain more timelyand ef...MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
...hile sparingnormal tissue, thus maybe advantageous over chemotherapy. Previousclinical studies have shown that single doses of the oncolyticherpes simplex virus NV1020 administered regionally are welltolerated and suggest that it may induce tumor regression. Interimdata from a Phase I/II trial testing NV1...Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
...e (TNSS) observed between theplacebo and PreHistin over the fourth, fifth and sixth weeks of thestudies. TNSS is a 12-point scale derived by summing and averagingall a.m. and p.m. scores for four symptoms: sneezing, runny nose,nasal congestion and nasal itch. Each symptom is given a score - 0(none), 1 (mi......lieve that oral vaccination will provideadvantages over injectable botulinum vaccines because of ease ofadministration and rapid distribution which can facilitate massinoculations in time of need. We hope to supply the vaccine forboth civilian and military use." The Company recently announced the publica......uce treatment costs of advanced CADpatients by 20% over a five-year period after treatment. Here is a lin...lly reduce total treatment costs, by as muchas 20% over five years. We are looking forward to gatheringevidence from the ongoing clinical trials to conclusi...Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
...int range. BPH afflicts approximately half of men over age 50 and close to90% of men by age 80. The disorder causes difficulties withurination associated with aging, such as urination at night, urgeto void frequently, hesitancy, weak stream, and other problems. More information about Nymox is available ......asimilar reduction of the EASI scores was measured over the studyperiod indicating no treatment effect for...nce of allergic diseases hasdramatically increased over the last decades, especially inindustrialized countries. It is estimated that today more than 20%of ...... thanpreviously estimated. This risk is 25 percent over 25 years and ismuch higher in women with multiple ...f atypia and calcification --with a 10.4-fold risk over the general population. "With the ability to stratify the risk of breast cancer in womenwith atypia......nist, Confers Superior Antithrombotic Activity over Clopidogrel in a Mouse Thrombosis Model," July 11 at 10:00 a.m. (CEST) in Room Mont Blanc. "Differential Effects of Anti-Platelet Drugs on Thrombus Formation and Thrombus Stability," July 11, 2007 at 10:45 a.m. (CEST) in Room Mont Bla......The conference call will be webcast simultaneously over theInternet. Please visit the Investor Relations section of theAdvanced Life Sciences corporate website <a target="_blank" href="http://www.advancedlifesciences.com/">www.advancedlifesciences.com .Alternatively, callers may participate in the......ldwide there areapproximately 74,000 new cases and over 45,000 deaths annually. About VELCADE VELCADE is being co-developed by Millennium Pharmaceuticals,Inc. and Johnson & Johnson Pharmaceutical Research &Development, L.L.C. Millennium is responsible for commercializationof VELCADE in the U.S.,...Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
...affects approximately 2 per cent of the population over the age of65, representing approximately 4 million...lion in 2003 and is forecast to grow substantially over the nextdecade with an increased prevalence of the disease as a consequenceof the ageing population....Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
...tients it is used in andpatients’ resistance over long-term use is common. TheDirectors believe tha...dical Center, Los Angelesexpressed high enthusiasm over HMPL-004. Dr. StephanTargan commented: “HMPL-004has a different mechanism of action. Ba...Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
...on of the twoagents tested will provide advantages over existing oralmedications; whether the company will present data from the phase1/2 study at a future medical meeting; and decisions by the FDAregarding ALKS 29 or other oral product candidates. For furtherinformation with respect to factors that could......The conference call will be webcast simultaneously over theInternet. Please visit the Investor Relations section of theAdvanced Life Sciences corporate website <a target="_blank" href="http://www.advancedlifesciences.com/">http://www.advancedlifesciences.com .Alternatively, callers may participate...Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
...f, given that cervicalcarcinogenesis often evolves over several decades. They alsohighlight increases in adverse reactions among women in the HPVvaccine group. Finally, the Comment authors raise the issue ofensuring the vaccine is distributed in the developing world, wherecervical cancer makes the larges...Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
...totic Kinesin Inhibitors Since their introduction over 40 years ago, anti-mitotic drugs(taxanes and vinca alkaloids) have advanced the treatment of cancerand are commonly used for the treatment of several tumortypes. However, these drugs have demonstrated limitedtreatment benefit against certain cancers......e resistance to other cancer treatments. To date, over 1,500 patients have been treated with perifosinein trials conducted both in the United States and Europe. Itssafety profile is distinctly different from that of most cytotoxicagents. It does not appear to cause myelosuppression (depression ofthe immu...... here are saying that nearly three years of median over allsurvival for REVLIMID patients is the longest t... second most common cancer of the blood, affecting over 80,000people in Europe and an estimated 750,000 worldwide at any onetime. EMP is a European umbrella......a Workshop brings together myelomaexperts from all over the world to review the latest data andtreatment protocols every two years. VELCADE has been available to patients, who have relapsed aftera previous treatment, in the United States since 2003 and in Europesince 2004. VELCADE as a single agent shows......ldwide there areapproximately 74,000 new cases and over 45,000 deaths annually. About VELCADE VELCADE is being co-developed by Millennium Pharmaceuticals,Inc. and Johnson & Johnson Pharmaceutical Research &Development, L.L.C. Millennium is responsible for commercializationof VELCADE in the U.S.,......ldwide there areapproximately 74,000 new cases and over 45,000 deaths annually. About VELCADE VELCADE is being co-developed by Millennium Pharmaceuticals,Inc. and Johnson & Johnson Pharmaceutical Research &Development, L.L.C. Millennium is responsible for commercializationof VELCADE in the U.S.,......previousstudies. As in previous studies conducted over the past five years andinvolving over 40,000 women, the candidate vaccine has been shownto be generally well-tolerated. Notes to Editors ......itshould not be assumed that the Company's silence over time meansthat actual events are bearing out as expressed or implied in suchforward-looking statements. Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestinal health, ...Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
... pressure[3]. SPP635 was safe and well tolerated over the 4 week period. Therewere no serious adverse ev...investigated as a therapy that mayprovide benefits over current therapies to reduce blood pressure,decrease salt retention and may protect end organs such a......ged from areduction of 0.1% to an increase of 1.0% over the same period. Inaddition to the HbA1c reduction...levels as well as improvements in glucosetolerance over a six month period following treatment withE1-I.N.T.(TM). Trends in increased insulin levels as meas...... for SLE or lupus nephritis in the United Statesin over forty years. Current induction treatments involve theoff-label use of existing cancer drugs such as cyclophosphamide,steroids, and immunosuppressants such as azathioprine. Thesetreatments can also have life-threatening side effects that can beworse t......patients taking genistein at both 12 and 24 months over bothbaseline and placebo. Key study findings inclu...rcent per yearover baseline and 6 percent per year over those taking theplacebo. -- No adverse events were reported in the study. Allparticipants were moni......wastransplantation immunobiology. Dr. O'Neill has over twenty five years' experience in his field,achieving recognition from his colleagues as the recipient of theJean Julliard Prize for Outstanding Research from the InternationalSociety of Blood Transfusion and International Society ofHematology, presen...